Group One Trading, L.P. Acurx Pharmaceuticals, Inc. Put Options Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding ACXP
# of Institutions
37Shares Held
2.71MCall Options Held
62.9KPut Options Held
56.9K-
Armistice Capital, LLC New York, NY1.08MShares$4.63 Million0.01% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$1.57 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$628,0730.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$624,3530.0% of portfolio
-
Morgan Stanley New York, NY106KShares$455,6020.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $49.6M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...